FilingSEC EDGAR6-K
Virax Biolabs Eliminates COO Role and Terminates Executive as Part of Restructuring
· SEC accepted
StageExecutive Change
Filing content
Following an operating model review, the company eliminated the COO role, terminated Dr. Nigel McCracken, and appointed Clement Monteil as Acting Chief Scientific Officer.
AI summary of the filing. Please also check the source.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…